The Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID) has approved the Department of Health's (DOH) guidelines for the use of rapid antibody test kits for COVID-19.
Cabinet Secretary Karlo Nograles announced the approval, stating that the specifics of these guidelines will be released on April 20.
Local government units (LGUs) are advised to purchase only rapid antibody test kits that have been accredited by the Food and Drug Administration (FDA).
Nograles emphasized that the administration of these rapid test kits must be done by a physician to prevent inaccurate results.
Currently, 16 rapid antibody test kits have received FDA approval.
Additionally, the country has acquired GeneXpert, a new COVID-19 testing kit with a faster turnaround time of 45 minutes compared to the standard PCR test.
Around 3,000 GeneXpert cartridges have arrived, and this new kit, along with PCR and rapid antibody tests, will be utilized.
The DOH aims to achieve its target of conducting 8,000 to 10,000 COVID-19 tests daily by the end of April.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.



